KDx Diagnostics, Cardiff University, Cardiff and Vale University Health Board and Cellpath announce Initiation of Accelerate project to develop a non-invasive URO17® urine test for Bladder Cancer in hematuria patients ...Middle East

CAMPBELL, Calif. and CARDIFF, Wales, May 18, 2021 /PRNewswire/ -- KDx Diagnostics, Inc. (KDx), Clinical Innovation Accelerator (CIA), Cardiff University, Cardiff and Vale University Health Board C&VUHB) and CellPath, announced today a partnership to develop a non-invasive urine test for...

Hence then, the article about kdx diagnostics cardiff university cardiff and vale university health board and cellpath announce initiation of accelerate project to develop a non invasive uro17 urine test for bladder cancer in hematuria patients was published today ( Wednesday 19/05/2021 - 06:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( KDx Diagnostics, Cardiff University, Cardiff and Vale University Health Board and Cellpath announce Initiation of Accelerate project to develop a non-invasive URO17® urine test for Bladder Cancer in hematuria patients )

Also on site :

• AI companies are building huge natural gas plants to power data centers. What could go wrong?
• The Trump Dictatorship Is Cracking Up
• Miami lands blue-chip quarterback for 2027 class